Prometheus Biosciences Inc Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$199.92

+0 (+0%)

At Close: Sep 14, 2023

Currently predicting for Fri, 19 Apr 2024

RXDX Predictions History

BE THE FIRST TO PREDICT

The excellent way of becoming a better trader

Easy to use
Enhance your skills
Predict as many as you like
Request predictions
Gather points

Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

About Prometheus Biosciences Inc

Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... RXDX Profile

Golden Star

Ticker	Date	Change	Price
ITCI	Apr 05	12.05%	$68.44
AKR	Apr 05	0.665%	$16.53
SARK	Mar 28	16.07%	$26.88
ARCC	Mar 25	1.04%	$20.12
STT	Mar 19	0.262%	$72.62
GGB	Mar 19	0.468%	$4.27
CAG	Mar 18	7.16%	$28.22
JBI	Mar 15	1.29%	$14.72
MASI	Mar 14	3.34%	$132.20
CMC	Mar 14	5.04%	$53.19

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In